KidneyCARE Study Achieves Enrollment Milestone for Patients

KidneyCARE Study Marks Significant Progress Towards Patient Empowerment

Empowering kidney disease patients while advancing research for enhanced outcomes

The National Kidney Foundation is thrilled to announce a pivotal achievement in the KidneyCARE (Community Access to Research Equity) Study. This groundbreaking initiative is designed to collect data from chronic kidney disease (CKD) patients through a comprehensive registry that combines both patient-reported information and Electronic Health Records (EHR). With over 1,000 participants enrolled from various regions, the study continues to excel, fostering a deeper understanding of CKD across the nation.

Kevin Longino, the CEO of NKF and a recipient of a kidney transplant, shared, "This milestone showcases the remarkable impact of patient engagement in research. Their participation helps illuminate the daily challenges faced by those with kidney disease, which is essential for enhancing care and treatment options." The insights gathered from patient experiences are aimed at driving forward research efforts, ultimately striving for improved clinical outcomes for kidney disease patients.

Understanding the Study's Scope and Impact

Who Can Participate?

The KidneyCARE Study welcomes adults aged 18 and older who identify with any form of kidney disease, including early-stage conditions, individuals on dialysis, and kidney transplant recipients. Participants are invited to fill out online surveys detailing their health status, family medical histories, lifestyle choices, and the impact of kidney disease on their lives. This blend of patient-derived data and clinical information from EHRs establishes a rich foundation for understanding this complex condition.

Diversity of Conditions Covered

The registry encompasses a wide array of kidney-related health issues. Major contributors to CKD like diabetes and hypertension are alongside rare conditions such as IgA Nephropathy, Lupus Nephritis, and Polycystic Kidney Disease. This inclusion of a diverse patient population aids in mapping disease progression patterns and may help shape future treatments tailored to specific patient needs.

How Participants Benefit from the KidneyCARE Study

Access to Educational Resources

By enrolling in the study, patients gain access to a wealth of educational materials tailored to their condition. The study's portal provides vital information regarding kidney disease management, effective self-care strategies, and potential clinical trial opportunities. Thus, participation not only furthers scientific inquiry but also enriches participants' own health journeys.

Establishing Collaborations with Health Systems

The KidneyCARE Study is engaged with major health systems, including Geisinger Health System, enhancing the quality of the data collected. These collaborations assist in merging patient experiences with real-world clinical data from EHRs, this dual perspective offers insights into both the clinical realities and lived experiences of those affected by CKD.

Lesley Inker, MD, who leads the research effort as a Principal Investigator, noted, "Reaching this milestone allows us to leverage the insights drawn from our participant data. Though the study is nascent, its extensive reach ensures that we gather meaningful information about diverse experiences with kidney disease, contributing to valuable future research on this critical health issue."

Support and Sponsorship for the KidneyCARE Study

The success of the KidneyCARE Study relies heavily on the generous contributions from sponsors such as Bayer AG, AstraZeneca, Novartis, Boehringer Ingelheim, and Apellis Pharmaceuticals. Their involvement plays a crucial role in fostering research that seeks to improve kidney health outcomes while establishing the registry as a vital resource for researchers in the kidney health community.

Participation Information and Engagement Opportunities

Individuals in the U.S. coping with chronic kidney disease are encouraged to join this transformative study from the comfort of their homes. The platform is designed for ease of access, making it simple for participants to engage in this essential research.

About the National Kidney Foundation

The National Kidney Foundation is on a mission to redefine the fight against kidney disease. Their objectives include preventing avoidable kidney complications, driving innovation to enhance the patient care experience, and addressing inequalities in kidney management, dialysis, and transplantation.

Frequently Asked Questions

What is the purpose of the KidneyCARE Study?

The KidneyCARE Study aims to collect patient-reported and electronic health data to better understand the experiences and challenges of living with chronic kidney disease.

Who can participate in the KidneyCARE Study?

Adults aged 18 and older with any form of kidney disease, including those on dialysis or with transplants, can participate, regardless of their spoken language.

What type of information do participants provide?

Participants share insights through online surveys about their health status, family history, lifestyle, and personal experiences with kidney disease.

How does the study benefit participants?

Participants gain access to educational resources, self-management tools, and the latest information about clinical trials that may support their health.

Who supports the KidneyCARE Study?

The study is backed by various sponsors, including pharmaceutical companies focused on advancing kidney research and improving patient outcomes.

About The Author

Hello Kelly Martin here, a financial and publicly traded company specialist committed to writing with clarity and sage advice. Having a wealth of experience and a thorough grasp of corporate dynamics and the financial environment, my main goal in writing blog posts and articles is to provide insightful analysis together with useful guidance. My objective is to arm readers with the information they need to comprehend the complexities of publicly traded companies and make wise financial decisions.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors to seasoned pros looking for fresh perspectives. My goal is to make corporate analysis and finance understandable and interesting so you may confidently negotiate the intricacies of the financial world. I appreciate you traveling with me toward success and financial literacy.

Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.